CVS HEALTH CORP (CVS)
US1266501006 - Common Stock
ChartMill assigns a Buy % Consensus number of 77% to CVS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 69.58. This target is 16.74% above the current price.
CVS was analyzed by 33 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about CVS.
In the previous month the buy percentage consensus was at a similar level.
CVS was analyzed by 33 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-30 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-05-30 | Baird | Initiate | Neutral |
| 2024-05-08 | Argus Research | Maintains | Buy -> Buy |
| 2024-05-07 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-05-07 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-05-02 | Mizuho | Maintains | Buy -> Buy |
| 2024-05-02 | UBS | Downgrade | Buy -> Neutral |
| 2024-05-02 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-05-02 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-05-02 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-05-02 | B of A Securities | Maintains | Buy -> Buy |
| 2024-05-01 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-05-01 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2024-04-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-04-08 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-04-04 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-03-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-03-06 | Barclays | Initiate | Equal-Weight |
| 2024-02-26 | Leerink Partners | Initiate | Outperform |
| 2024-02-08 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-02-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-12-22 | HSBC | Initiate | Buy |
| 2023-12-11 | TD Cowen | Maintains | Outperform -> Outperform |
| 2023-11-21 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-11-02 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-11-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-09-19 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2023-09-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-09-12 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
| 2023-09-01 | Piper Sandler | Maintains | Overweight -> Overweight |